McKesson

Latest from McKesson


Dr Marcus Neubauer Outlines the Benefits of the OCM and the Potential Successor Model

October 01, 2021

The Oncology Care Model (OCM) was a great program that led to practice transformation and improved patient care, but there needs to be a way to address the high cost of cancer therapies, said Marcus Neubauer, MD, chief medical officer of the US Oncology Network.

In Oncology Clinical Pathways, the Variability Isn’t With the Drugs

September 25, 2021

Experts who took part in Patient-Centered Oncology Care® 2021 said when guidelines recommend high-cost targeted therapies or immunotherapies, the focus must turn to areas such as imaging, diagnostic tests, and other elements that contribute to the cost of care.

What's Next After OCM? Possibly a Gap and Something Mandatory, Experts Predict

September 25, 2021

With the Oncology Care Model (OCM) slated to end in 2022, the successor model is still not in place. According to panelists, there is likely going to be a gap after OCM ends and the new model begins, but more importantly, practices should prepare for the new model to be mandatory.

Oncology Value Coalition: Disparities in Cancer Care—Sources and Solutions, Part 3

April 22, 2021

In the inaugural Oncology Value Coalition from The American Journal of Managed Care®, Kashyap Patel, MD, led a discussion with Debra Patt, MD, PhD, MBA; and Karen Winkfield, MD, PhD, exploring findings that suggest minority groups develop cancer at higher rates and experience worse outcomes than nonminority groups.

Oncology Value Coalition: Disparities in Cancer Care—Sources and Solutions, Part 2

April 22, 2021

In the inaugural Oncology Value Coalition from The American Journal of Managed Care®, Kashyap Patel, MD, led a discussion with Debra Patt, MD, PhD, MBA; and Karen Winkfield, MD, PhD, exploring findings that suggest minority groups develop cancer at higher rates and experience worse outcomes than nonminority groups.

Oncology Value Coalition: Disparities in Cancer Care—Sources and Solutions, Part 1

April 22, 2021

In the inaugural Oncology Value Coalition from The American Journal of Managed Care®, Kashyap Patel, MD, led a discussion with Debra Patt, MD, PhD, MBA; and Karen Winkfield, MD, PhD, exploring findings that suggest minority groups develop cancer at higher rates and experience worse outcomes than nonminority groups.

Dr Lalan Wilfong on the Upcoming Quality Metrics in Cancer Care Discussion at Community Oncology Conference 2021

April 05, 2021

Lalan Wilfong, MD, executive vice president, Value Based Care & Quality Programs, Texas Oncology, and co-chair, Payment Reform, Community Oncology Alliance, discusses implications of quality metrics in cancer care and what perspectives on the topic he is looking forward to hearing at the 2021 Community Oncology Conference.

Best Practices Drive Better Payer Negotiations

December 01, 2020

In today's managed care environment, it is important that contracts between practices and payers include reciprocal language that affords a practice protection over processes, decisions, and changes to the agreement over time, while aligning with its business operation.